Altered nigrostriatal dopaminergic and noradrenergic system prompted by systemic lead toxicity versus a treatment by curcumin-III in the desert rodent Meriones shawi.


Journal

Comptes rendus biologies
ISSN: 1768-3238
Titre abrégé: C R Biol
Pays: France
ID NLM: 101140040

Informations de publication

Date de publication:
Historique:
received: 13 06 2019
revised: 15 07 2019
accepted: 16 07 2019
pubmed: 3 9 2019
medline: 24 12 2019
entrez: 3 9 2019
Statut: ppublish

Résumé

Exposure to lead is a threat factor for neurodegenerative disorders progress as it could trigger dopaminergic deficiency. We aimed herein to assess the effect of acute lead exposure (25mg/kg B.W i.p.) during three continuous days on the dopaminergic and noradrenergic systems together with locomotor performance in Meriones shawi (M. shawi), then the neuroprotective potential of curcumin-III (30mg/kg B.W) by oral gavage. Pb-exposed M. shawi exhibited increased tyrosine hydroxylase (TH) immunoreactivity in substantia nigra compacta (SNc), ventral tegmental area (VTA), locus coeruleus (LC), and dorsal striatum (DS), unlike the controls. This was correlated with decreased locomotor performance. A noticeable protective effect by co-treatment with curcumin-III was observed; in consequence, TH-immunoreactivity and locomotor disturbance were restored in Pb-treated Meriones. Our data results proved, on the one hand, an evident neurotoxic effect of acute Pb exposure and, on the other hand, a potent therapeutic effect of curcumin-III. Thereby, this compound may be recommended as a neuroprotective molecule for neurodegenerative disorders involving catecholaminergic impairment initiated by metallic elements.

Identifiants

pubmed: 31474522
pii: S1631-0691(19)30066-6
doi: 10.1016/j.crvi.2019.07.004
pii:
doi:

Substances chimiques

Neuroprotective Agents 0
curcumin III 33171-05-0
Curcumin IT942ZTH98

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

192-198

Informations de copyright

Copyright © 2019. Published by Elsevier Masson SAS.

Auteurs

Lahcen Tamegart (L)

Cadi Ayyad University, Faculty of Sciences Semlalia, Neurosciences, Pharmacology and Environment Unit, Avenue My Abdellah, B.P. 2390, Marrakech, Morocco.

Abdellatif Abbaoui (A)

Cadi Ayyad University, Faculty of Sciences Semlalia, Neurosciences, Pharmacology and Environment Unit, Avenue My Abdellah, B.P. 2390, Marrakech, Morocco.

Abdelaati El Khiat (A)

Cadi Ayyad University, Faculty of Sciences Semlalia, Neurosciences, Pharmacology and Environment Unit, Avenue My Abdellah, B.P. 2390, Marrakech, Morocco.

Moulay Mustapha Bouyatas (MM)

Cadi Ayyad University, Faculty of Sciences Semlalia, Neurosciences, Pharmacology and Environment Unit, Avenue My Abdellah, B.P. 2390, Marrakech, Morocco; Cadi Ayyad University, Multidisciplinary Faculty of Safi, Department of Biology, Safi, Morocco.

Halima Gamrani (H)

Cadi Ayyad University, Faculty of Sciences Semlalia, Neurosciences, Pharmacology and Environment Unit, Avenue My Abdellah, B.P. 2390, Marrakech, Morocco. Electronic address: gamrani@uca.ac.ma.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH